Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Recombination protein A (RecA) is a highly conserved bacterial enzyme that plays a central role in DNA repair and homologous recombination [1, 5]. It functions by forming a helical nucleoprotein filament on single-stranded DNA, which then searches for and invades homologous double-stranded DNA to facilitate strand exchange and repair [8, 9]. In addition to its recombinase activity, RecA acts as a co-protease that triggers the bacterial SOS response by stimulating the self-cleavage of the LexA repressor [11, 12]. This induction leads to the expression of over 40 genes involved in DNA repair, survival, and stress-induced mutagenesis, which often contributes to the development of antibiotic resistance [13, 17]. Consequently, RecA is an attractive therapeutic target for the development of antibiotic adjuvants designed to sensitize pathogens to existing drugs and prevent the emergence of multi-drug resistance [2, 10]. Small molecule inhibitors and peptides targeting RecA's ATPase activity or filament formation are currently being explored to attenuate the SOS response and enhance the efficacy of DNA-damaging antibiotics like fluoroquinolones [3, 18].
Inhibition of RecA ATPase activity, inhibition of RecA-ssDNA nucleoprotein filament formation, and blocking of the SOS response by preventing LexA cleavage [2, 3, 10, 13].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Recombination protein A (RecA) (RecA).